Catheter-Based Renal Denervation for Treatment of Patients With Treatment-Resistant Hypertension: 36 Month Results From the SYMPLICITY HTN-2 Randomized Clinical Trial
Renal Denervation
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers
12-Month Blood Pressure Results of Catheter-Based Renal Artery Denervation for Resistant Hypertension: The SYMPLICITY HTN-3 Trial.
Renal Denervation.
Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension